SLC5A2 and liver dysplastic nodule: In clinical practice, DN is typically managed with a variety of drugs, including angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARBs), non-steroidal mineralocorticoid receptor antagonists (NS-MRAs), fexofenadine, and sodium-glucose cotransporter-2 (SGLT2) inhibitors.